COV — Toxotis Investments Public Income Statement
0.000.00%
FinancialsMicro Cap
Annual income statement for Toxotis Investments Public, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | IFRS | IFRS | IFRS | — | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.073 | 0.538 | 0.204 | -0.023 | 0.071 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.157 | 0.201 | 0.096 | 0.3 | 0.102 |
| Operating Profit | -0.084 | 0.338 | 0.107 | -0.323 | -0.032 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.094 | 0.325 | 0.046 | -0.43 | -0.151 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.11 | 0.23 | 0.041 | -0.409 | -0.151 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.11 | 0.23 | 0.041 | -0.409 | -0.151 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.11 | 0.23 | 0.041 | -0.409 | -0.151 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.005 | 0.011 | 0.002 | -0.02 | -0.007 |